Among older people it is quite common to lose sight, since after the retina the blood vessels grow. Now, an RNA based therapy has given good results in a clinical session. In particular, small parts of the RNA have been used to block the production of the factor that the growth of blood vessels. The kit used by the RNA has been baptized as Bevasiranib, and it is expected that all clinical sessions will be completed by 2009.